ArticleRSC chemical biology2022
A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and
Abstract read
In one paragraph
Article in RSC chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Efficacy and Safety of a Protein-Based SARS-CoV-2 Vaccine: A Randomized Clinical Trial.JAMA network open · 2023Trial
- Enhanced immunogenicity of COVID-19 RBD fused to mutant scorpion's phospholipase D for vaccine development.New microbes and new infections · 2025Article
- Mucosal Vaccination Against SARS-CoV-2 Using Human ProbioticVaccines · 2025Article
- Unveiling the role of the upper respiratory tract microbiome in susceptibility and severity to COVID-19.Frontiers in cellular and infection microbiology · 2025Article
- Viral Mimetic Bacterial Outer Membrane Vesicles for Targeting Angiotensin-Converting Enzyme 2.International journal of nanomedicine · 2025Article
- Hybrid response to SARS-CoV-2 andHuman vaccines & immunotherapeutics · 2024Article
- Comparative assessment of a COVID-19 vaccine after technology transfer to Iran from critical quality attributes to clinical and immunogenicity aspects.Scientific reports · 2024Article
- Bacterial Membrane Vesicles as a Novel Vaccine Platform against SARS-CoV-2.Current microbiology · 2024Review
- Studying SARS-CoV-2 interactions using phage-displayed receptor binding domain as a model protein.Scientific reports · 2024Article
- COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition.NPJ vaccines · 2023Article
- Conformational characterization of the mammalian-expressed SARS-CoV-2 recombinant receptor binding domain, a COVID-19 vaccine.Biological research · 2023Article
- Development of a scalable single process for producing SARS-CoV-2 RBD monomer and dimer vaccine antigens.Frontiers in bioengineering and biotechnology · 2023Article
- A highly immunogenic vaccine platform against encapsulated pathogens using chimeric probiotic Escherichia coli membrane vesicles.NPJ vaccines · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
46 authors.
Darielys Santana-MederosFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.ORCID https://orcid.org/0000-0001-5333-554X
Rocmira Perez-NicadoFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.ORCID https://orcid.org/0000-0002-1657-6130
Yanet ClimentFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.ORCID https://orcid.org/0000-0002-2824-6374
Laura RodriguezFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.ORCID https://orcid.org/0000-0003-0171-4681
Belinda Sanchez RamirezCenter of Molecular Immunology P.O. Box 16040 216 St. Havana Cuba.
Sonia Perez-RodriguezNational Toxicology Center Havana 11500 Cuba.
Meybi RodriguezFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.
Claudia LabradaFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.ORCID https://orcid.org/0000-0003-3237-2063
Tays HernandezCenter of Molecular Immunology P.O. Box 16040 216 St. Havana Cuba.
Marianniz DiazCenter of Molecular Immunology P.O. Box 16040 216 St. Havana Cuba.ORCID https://orcid.org/0000-0001-6838-2568
Ivette OrosaCenter of Molecular Immunology P.O. Box 16040 216 St. Havana Cuba.ORCID https://orcid.org/0000-0003-3818-3271
Ubel RamirezFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.
Reynaldo OlivaFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.ORCID https://orcid.org/0000-0001-8198-9161
Raine GarridoFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.ORCID https://orcid.org/0000-0002-6987-2814
Felix CardosoFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.
Mario LandysFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.
Roselyn MartinezFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.
Humberto GonzalezFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.
Tamara HernandezFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.
Rolando Ochoa-AzzeFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.
Jose L PerezFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.
Juliet EnriquezNational Civil Defense Research Laboratory Mayabeque 32700 Cuba.
Nibaldo GonzalezNational Civil Defense Research Laboratory Mayabeque 32700 Cuba.
Yenicet InfanteNational Civil Defense Research Laboratory Mayabeque 32700 Cuba.
Luis A EspinosaCenter for Genetic Engineering and Biotechnology Ave 31 e/158 y 190 Havana 10600 Cuba.ORCID https://orcid.org/0000-0002-6363-855X
Yassel RamosCenter for Genetic Engineering and Biotechnology Ave 31 e/158 y 190 Havana 10600 Cuba.
Luis Javier GonzálezCenter for Genetic Engineering and Biotechnology Ave 31 e/158 y 190 Havana 10600 Cuba.
Carmen ValenzuelaInstitute of Cybernetics, Mathematics and Physics Havana 10400 Cuba.
Ana Victoria CasadesusCenter of Molecular Immunology P.O. Box 16040 216 St. Havana Cuba.
Briandy FernandezCenter of Molecular Immunology P.O. Box 16040 216 St. Havana Cuba.ORCID https://orcid.org/0000-0001-7103-8581
Gertrudis RojasCenter of Molecular Immunology P.O. Box 16040 216 St. Havana Cuba.ORCID https://orcid.org/0000-0001-6335-6264
Beatriz Pérez-MassónCenter of Molecular Immunology P.O. Box 16040 216 St. Havana Cuba.ORCID https://orcid.org/0000-0002-0813-210X
Yaima TundidorCenter of Molecular Immunology P.O. Box 16040 216 St. Havana Cuba.ORCID https://orcid.org/0000-0002-2500-2876
Ernesto BermudezCenter of Molecular Immunology P.O. Box 16040 216 St. Havana Cuba.
Claudia A PlasenciaCenter of Molecular Immunology P.O. Box 16040 216 St. Havana Cuba.
Tammy BoggianoCenter of Molecular Immunology P.O. Box 16040 216 St. Havana Cuba.ORCID https://orcid.org/0000-0002-6676-2011
Eduardo OjitoCenter of Molecular Immunology P.O. Box 16040 216 St. Havana Cuba.ORCID https://orcid.org/0000-0001-7300-2478
Fabrizio ChiodoFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.ORCID https://orcid.org/0000-0003-3619-9982
Sonsire FernandezFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.ORCID https://orcid.org/0000-0001-5329-5971
Françoise PaquetCentre de Biophysique Moléculaire, CNRS UPR 4301, rue Charles Sadron F-45071 Orléans Cedex 2 France.ORCID https://orcid.org/0000-0001-8838-3445
Cheng FangShanghai Fenglin Glycodrug Promotion Center Shanghai 200032 China.
Guang-Wu ChenChengdu Olisynn Biotech. Co. Ltd., and State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University Chengdu 610041 People's Republic of China.
Daniel G RiveraLaboratory of Synthetic and Biomolecular Chemistry, Faculty of Chemistry, University of Havana, Zapata y G Havana 10400 Cuba dgr@fq.uh.cu.ORCID https://orcid.org/0000-0002-5538-1555
Yury Valdes-BalbinFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.
Dagmar Garcia-RiveraFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.ORCID https://orcid.org/0000-0002-2099-1791
Vicente Verez BencomoFinlay Vaccine Institute 200 and 21 Street Havana 11600 Cuba yvbalbin@finlay.edu.cu dagarcia@finlay.edu.cu vicente.verez@finlay.edu.cu.ORCID https://orcid.org/0000-0001-5596-6847
Funding
No grant is acknowledged in the PubMed record.
Abstract
SARS-CoV-2 infection is mediated by the interaction of the spike glycoprotein trimer
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.